GGrantIndex
← Search

Cancer Health Outcomes and Control Research Program (CO) (Project-007)

$4,734P30FY2018CANIH

Vanderbilt University Medical Center, Nashville TN

Investigators

Linked publications, trials & patents

Trial NCT07016399Trial NCT06593106Trial NCT05501665Trial NCT05361720Trial NCT04765072Trial NCT02702310Trial NCT02685631Trial NCT02677883Trial NCT02676752Trial NCT02672475Trial NCT02658487Trial NCT02600533Trial NCT02489422Trial NCT02480114Trial NCT02457910Trial NCT02448225Trial NCT02440737Trial NCT02374931Trial NCT02359851Trial NCT02324881Trial NCT02296112Trial NCT02269111Trial NCT02240381Trial NCT02236546Trial NCT02170272Trial NCT02151539Trial NCT02148406Trial NCT01996527Trial NCT01928160Trial NCT01901367Trial NCT01660971Trial NCT01230515Trial NCT01198535Trial NCT01141218Trial NCT01098669Trial NCT01098643Trial NCT01096407Trial NCT01096394Trial NCT01096381Trial NCT01077440Trial NCT01031446Trial NCT01013506Trial NCT01009931Trial NCT01007422Trial NCT00993694Trial NCT00993135Trial NCT00987766Trial NCT00984542Trial NCT00984490Trial NCT00983268Trial NCT00957736Trial NCT00949052Trial NCT00930930Trial NCT00900406Trial NCT00900003Trial NCT00899769Trial NCT00899626Trial NCT00899457Trial NCT00899301Trial NCT00899028Trial NCT00898742Trial NCT00898638Trial NCT00898430Trial NCT00898313Trial NCT00897988Trial NCT00897832Trial NCT00897793Trial NCT00897650Trial NCT00897468Trial NCT00897403Trial NCT00897117Trial NCT00896948Trial NCT00896675Trial NCT00892801Trial NCT00875238Trial NCT00840814Trial NCT00837876Trial NCT00835679Trial NCT00801346Trial NCT00765245Trial NCT00755040Trial NCT00675636Trial NCT00670644Trial NCT00670605Trial NCT00670046Trial NCT00666211Trial NCT00656604Trial NCT00653250Trial NCT00651976Trial NCT00651716Trial NCT00647218Trial NCT00626873Trial NCT00625417Trial NCT00625066Trial NCT00616590Trial NCT00601991Trial NCT00573404Trial NCT00550537Trial NCT00544648Trial NCT00533884

Abstract

PROJECT 007 ? CANCER HEALTH OUTCOMES AND CONTROL RESEARCH PROGRAM PROJECT SUMMARY/ABSTRACT The overarching mission of the Cancer Health Outcomes and Control Research Program (CO) is to foster research that 1) improves outcomes for patients and families with or at risk for a cancer diagnosis and 2) reduces the public health burden of malignancies across the entire cancer care continuum. Research in CO is categorized into three thematic domains: 1) prevention and early detection in healthy and at-risk individuals; 2) treatment-related outcomes around cancer therapy and; 3) survivorship and palliative care. CO supports research across these three domains through the following specific aims, with the goal of translating that research to the clinic and community to meet our mission: ? To establish and further develop population and community-based resources for research focused on cancer prevention, early detection and improved outcomes ? To assess short- and long-term patient-centered outcomes following a cancer diagnosis and develop strategies to improve outcomes ? To identify socio-behavioral factors influencing cancer prevention, treatment and outcomes ? To assess the magnitude and determinants of disparities in cancer health outcomes and control associated with age, race, gender, geography and other group characteristics and develop strategies to decrease such disparities There are 26 program members from ten departments and five schools with $4.1M in NCI funding and $4.6M in other peer-reviewed cancer-related funding. Out of 310 publications, 13% are intra-programmatic and 32% are inter-programmatic. Members also have 106 collaborative publications with investigators at other institutions.

View original record on NIH RePORTER →